These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 26142627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aptamer-functionalized in situ injectable hydrogel for controlled protein release.
    Soontornworajit B, Zhou J, Zhang Z, Wang Y.
    Biomacromolecules; 2010 Oct 11; 11(10):2724-30. PubMed ID: 20809645
    [Abstract] [Full Text] [Related]

  • 4. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X, Zhao Q, Qiu L.
    J Control Release; 2013 Oct 28; 171(2):152-62. PubMed ID: 23777885
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Programmable release of multiple protein drugs from aptamer-functionalized hydrogels via nucleic acid hybridization.
    Battig MR, Soontornworajit B, Wang Y.
    J Am Chem Soc; 2012 Aug 01; 134(30):12410-3. PubMed ID: 22816442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
    Xu L, He XY, Liu BY, Xu C, Ai SL, Zhuo RX, Cheng SX.
    Colloids Surf B Biointerfaces; 2018 Nov 01; 171():24-30. PubMed ID: 30005287
    [Abstract] [Full Text] [Related]

  • 10. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W, Zhou Y, Wu J, Liu Z, Zhao H, Liu J, Ding J.
    J Drug Target; 2014 Jan 01; 22(1):57-66. PubMed ID: 24156476
    [Abstract] [Full Text] [Related]

  • 11. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J, Mokhtarzadeh A.
    Curr Drug Deliv; 2018 Jan 01; 15(9):1323-1329. PubMed ID: 30039760
    [Abstract] [Full Text] [Related]

  • 12. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
    Shiao YS, Chiu HH, Wu PH, Huang YF.
    ACS Appl Mater Interfaces; 2014 Dec 24; 6(24):21832-41. PubMed ID: 24949657
    [Abstract] [Full Text] [Related]

  • 13. Affinity hydrogels for controlled protein release using nucleic acid aptamers and complementary oligonucleotides.
    Soontornworajit B, Zhou J, Snipes MP, Battig MR, Wang Y.
    Biomaterials; 2011 Oct 24; 32(28):6839-49. PubMed ID: 21684002
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
    Taghdisi SM, Danesh NM, Ramezani M, Lavaee P, Jalalian SH, Robati RY, Abnous K.
    Eur J Pharm Biopharm; 2016 May 24; 102():152-8. PubMed ID: 26987703
    [Abstract] [Full Text] [Related]

  • 19. Aptamer-functionalized superporous hydrogels for sequestration and release of growth factors regulated via molecular recognition.
    Battig MR, Huang Y, Chen N, Wang Y.
    Biomaterials; 2014 Sep 24; 35(27):8040-8. PubMed ID: 24954732
    [Abstract] [Full Text] [Related]

  • 20. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
    Esawi E, Alshaer W, Mahmoud IS, Alqudah DA, Azab B, Awidi A.
    Int J Mol Sci; 2021 Nov 30; 22(23):. PubMed ID: 34884745
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.